Literature DB >> 15527859

Emergence of attenuated West Nile virus variants in Texas, 2003.

C Todd Davis1, David W C Beasley, Hilda Guzman, Marina Siirin, Ray E Parsons, Robert B Tesh, Alan D T Barrett.   

Abstract

In order to understand how West Nile virus (WNV) has evolved since its introduction into North America, we have studied the genetic and phenotypic variation among WNV isolates collected in various areas during consecutive transmission seasons. The present report describes for the first time phenotypic changes occurring in the North American WNV population. Several isolates collected in Texas during 2003 display a small plaque (sp) and temperature sensitive (ts) phenotype, as well as reduced replication in cell culture, in comparison to isolates collected in 2002 and New York in 1999. Studies of mouse neuroinvasiveness/neurovirulence also indicate that several of these isolates were attenuated in neuroinvasiveness, but not for neurovirulence. The complete genome and deduced amino acid sequences of several of these isolates have been determined in order to map the mutations responsible for this phenotypic variation. These data indicate microevolution of WNV and the emergence of isolates exhibiting phenotypic variation.

Entities:  

Mesh:

Year:  2004        PMID: 15527859     DOI: 10.1016/j.virol.2004.09.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  Nonconsensus West Nile virus genomes arising during mosquito infection suppress pathogenesis and modulate virus fitness in vivo.

Authors:  Gregory D Ebel; Kelly A Fitzpatrick; Pei-Yin Lim; Corey J Bennett; Eleanor R Deardorff; Greta V S Jerzak; Laura D Kramer; Yangsheng Zhou; Pei-Yong Shi; Kristen A Bernard
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates.

Authors:  Ashley N Brown; Kim A Kent; Corey J Bennett; Kristen A Bernard
Journal:  Virology       Date:  2007-08-06       Impact factor: 3.616

3.  A combination of naturally occurring mutations in North American West Nile virus nonstructural protein genes and in the 3' untranslated region alters virus phenotype.

Authors:  C Todd Davis; Sareen E Galbraith; Shuliu Zhang; Melissa C Whiteman; Li Li; Richard M Kinney; Alan D T Barrett
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

4.  Mutational analysis of the West Nile virus NS4B protein.

Authors:  Jason A Wicker; Melissa C Whiteman; David W C Beasley; C Todd Davis; Charles E McGee; J Ching Lee; Stephen Higgs; Richard M Kinney; Claire Y H Huang; Alan D T Barrett
Journal:  Virology       Date:  2012-02-06       Impact factor: 3.616

5.  West Nile virus-associated acute flaccid paralysis.

Authors:  Ashely Alker
Journal:  BMJ Case Rep       Date:  2015-05-02

Review 6.  West Nile virus: A re-emerging pathogen revisited.

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2012-04-12

7.  Short report: comparison of oral infectious dose of West Nile virus isolates representing three distinct genotypes in Culex quinquefasciatus.

Authors:  Dana L Vanlandingham; Charles E McGee; Kimberly A Klingler; Sareen E Galbraith; Alan D T Barrett; Stephen Higgs
Journal:  Am J Trop Med Hyg       Date:  2008-12       Impact factor: 2.345

8.  West nile virus: characteristics of an african virus adapting to the third millennium world.

Authors:  Marina Monini; Emiliana Falcone; Luca Busani; Roberto Romi; Franco Maria Ruggeri
Journal:  Open Virol J       Date:  2010-04-22

Review 9.  West Nile virus and its emergence in the United States of America.

Authors:  Kristy O Murray; Eva Mertens; Philippe Despres
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

10.  Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains.

Authors:  Elizabeth M Botha; Wanda Markotter; Mariaan Wolfaardt; Janusz T Paweska; Robert Swanepoel; Gustavio Palacios; Louis H Nel; Marietjie Venter
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.